In 2020, Fidelis Pharmaceuticals made available the first FDA-indexed extended-release buprenorphine formulation (Ethiqa XR®(link is external)) specifically for mice and rats. Recent FDA guidance GFI #256 Compounding Animal Drugs from Bulk Drug Substances has been implemented that may impact the future use of Buprenorphine ER (formerly Buprenorphine SR). Campus Veterinary Services encourages labs to review their use […]
Environmental sampling in IVS and PLAR facilities will reduce the number of live sentinel animals needed and increase sensitivity and accuracy of testing, among other benefits. Learn more in this letter from Dr. Woodford, and the PowerPoint presentation “Replacing Sentinel Rodents with Environmental Health Monitoring.”
As of April 2023, standard concentration of xylazine (20 mg/ml-AnaSed) is no longer available. This specific formulation was manufactured by a supplier (Akorn Pharmaceuticals) that has gone out of business and as such, the product has been discontinued. Currently, there are no other suppliers manufacturing a similar xylazine injectable product with a 20 mg/ml concentration. […]
As demolition of Johnson Hall continues, removal of the foootings is scheduled to commence on or around February 20th. This will include a period of massive jackhammering and concrete grinding that will produce significant noise and vibration. Please refer to the Johnson Hall Demolition Schedule and reach out to your facility manager or IVS Assistant […]
Environmental sampling in IVS and PLAR facilities will reduce the number of live sentinel animals needed and increase sensitivity and accuracy of testing, among other benefits. Learn more in this letter from Dr. Woodford, and the PowerPoint presentation “Replacing Sentinel Rodents with Environmental Health Monitoring.”
Demolition of Johnson Hall on WSU’s Pullman campus is underway. This activity is expected to produce significant noise and vibration, especially during periods of jack hammering. Please refer to the Johnson Hall Demolition Schedule and reach out to your facility manager or IVS Assistant Director if you have any questions or concerns.